• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Inovio Pharma (NQ: INO )

    5.555 +0.035 (+0.63%)
    Streaming Delayed Price Updated: 1:40 PM EST, Nov 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 173,833
    Open 5.510
    Bid (Size) 5.550 (56)
    Ask (Size) 5.560 (8)
    Prev. Close 5.520
    Today's Range 5.505 - 5.760
    52wk Range 3.888 - 14.75
    Shares Outstanding 210,356,896
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Analyst Verdict: Inovio Pharmaceuticals In The Eyes Of 4 Experts
    Via Benzinga
    Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
    EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NYSE:PFE),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END 
    Via FinancialNewsMedia
    Exposures COVID-19

    Performance

    YTD
    -17.92%
    -17.92%
    1 Month
    +4.22%
    +4.22%
    3 Month
    -37.83%
    -37.83%
    6 Month
    -53.24%
    -53.24%
    1 Year
    +17.31%
    +17.31%

    More News

    Read More
    Inovio Pharmaceuticals (INO) Q2 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    INO Stock Earnings: Inovio Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    Peering Into Inovio Pharmaceuticals's Recent Short Interest
    Via Benzinga
    Recap: Inovio Pharmaceuticals Q4 Earnings
    Via Benzinga
    Preview: Inovio Pharmaceuticals's Earnings
    Via Benzinga
    Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
    From FN Media Group LLC
    Via GlobeNewswire
    Better Buy: Inovio Pharmaceuticals vs. Novavax
    Via The Motley Fool
    Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst
    Via Benzinga
    Exposures Product Safety
    Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    INO Stock Earnings: Inovio Pharmaceuticals Misses EPS for Q1 2024
    Via InvestorPlace
    This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
    Via The Motley Fool
    Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Inovio Pharmaceuticals Stock Is Diving Today: What's Happening?
    Via Benzinga
    Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
    Via InvestorPlace
    Live Nation Entertainment, Groupon And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    Inovio Pharmaceuticals (INO) Q4 2023 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    INO Stock Earnings: Inovio Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    Victoria's Secret, Inovio Pharmaceuticals, Broadcom, Aptorum Group, Tesla: Why These 5 Stocks Are On Investors' Radars Today
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Earnings Scheduled For March 6, 2024
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.